🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Financials Sector SEC Filings — August 10, 2026

The five filings in this S&P 500 Financials digest present a bifurcated picture. Berkshire Hathaway’s Q2 2026 results are a clear standout, with net earnings doubling to $25.7B on a 10% revenue rise, driven by $16.1B in investment gains. However, a massive $61.6B swing in investing cash flows and a sharp decline in cash reserves signal a shift from net selling to aggressive deployment into equities, acquisitions ($9.7B in H1 2026 vs. $101M in H1 2025), and record $4.5B in buybacks. In contrast, insider selling at Capital One (minor) and a large $25M block sale by J.P. Morgan’s asset management arm in its private markets fund inject caution into the asset management sub-sector. T. Rowe Price’s crypto ETF remains a non-event, and Progressive's 8-K is purely procedural. The dominant theme is capital rotation—Berkshire is actively recycling its massive cash hoard into yield and growth, while J.P. Morgan’s sell-off may reflect portfolio rebalancing or profit-taking in private market exposure.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 10, 2026

The 14 filings for the S&P 500 Consumer Staples stream are overwhelmingly dominated by routine insider equity awards at Procter & Gamble (PG), indicating a standard compensation cycle with no material trading signals. The only actionable signal comes from Hershey (HSY), where the 10% owner (Hershey Trust) sold ~$1.25M in stock under a 10b5-1 plan, a pre-planned but notable reduction. Archer-Daniels-Midland (ADM) filed a routine 8-K with no new financial data, offering no insights. The period-over-period, forward-looking, and capital allocation enriched data fields are entirely absent from all filings, preventing any trend analysis, guidance assessments, or cross-company comparisons. The key takeaway is a lack of material, actionable intelligence from this batch, with the Hershey insider sale being the sole event warranting attention.

13 high priority 1 medium 14 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 10, 2026

The sole filing in this digest is a Form 4 from Waste Management Inc., reporting a gift of 5,357 shares by EVP & CFO Reed David L., leaving him with 5,357 shares. The transaction is non-market and carries neutral sentiment, indicating no direct signal of management conviction. With only one filing, portfolio-level trend analysis is limited, but the event highlights a potential estate planning or personal liquidity move by a key insider. The absence of market transactions, guidance changes, or capital allocation updates suggests a quiet period for the S&P 500 Industrials stream. Investors should monitor for any subsequent insider sales or changes in executive holdings that could signal a shift in sentiment.

1 high priority 1 total filings
· daily

Insider Trading Pulse — August 10, 2026

The August 10, 2026 insider trading pulse reveals a market with starkly divergent insider conviction. While the day is dominated by a broad wave of bullish insider buying at **Taiwan Semiconductor Manufacturing Co (TSMC)**, with 10 separate executives collectively purchasing shares, signaling strong internal confidence in the company's trajectory, the most significant capital movement is a massive $13.6M sale by the Executive Chair of **Floor & Decor Holdings**, representing a near-total liquidation of his stake. This creates a clear 'risk-on' signal for the semiconductor sector versus a 'risk-off' warning for home improvement retail. Other notable bullish signals include a $6.17M open-market purchase by the CEO of **51Talk Online Education Group** and a $498K buy by the CEO of **PROCEPT BioRobotics**, both indicating deep management conviction. On the bearish side, the CEO of **Karooooo Ltd.** sold $1.19M in stock, and the CEO of **Allot Ltd.** sold $222K, adding to a pattern of insider selling in the tech services space. The data suggests a market where insiders are betting heavily on specific growth stories (semiconductors, education tech, medtech) while reducing exposure to consumer cyclical and certain tech-enabled services.

49 high priority 1 medium 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 10, 2026

The 21 filings for the Dow Jones 30 stream present a mixed picture dominated by routine insider transactions and a few high-impact events. The most critical development is UnitedHealth Group's stellar Q2 2026, where a 61% surge in net earnings and a 55% jump in operating earnings signal a powerful turnaround in medical cost management, despite flat revenue growth. This is a significant outlier compared to the stream's overall lack of major operational updates. Conversely, a $25 billion debt offering by Alphabet Inc. introduces a major capital structure shift, increasing leverage for general corporate purposes. The remaining filings are overwhelmingly routine insider transactions, primarily stock awards at Procter & Gamble and Amgen, which offer limited actionable signals. A notable bearish signal comes from a Merck executive's $644K stock sale, and a large $25M sale by an affiliate of JPMorgan in a private markets fund warrants attention. The period-over-period data from UnitedHealth is the key differentiator, providing the only deep financial trend analysis in this batch, while the rest of the stream is characterized by corporate governance noise rather than fundamental business shifts.

21 high priority 21 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 10, 2026

This digest covers five US SEC filings, all flagged for corporate distress signals. The dominant theme is Nasdaq non-compliance and delisting risk, with three companies (Arcadia Biosciences, Lexaria Bioscience, and Northann Corp.) receiving explicit notices. A fourth, Construction Partners, faces a governance-related compliance issue. The fifth, Faraday Future, has resolved its bid price deficiency but remains in a precarious financial state. Period-over-period comparisons were largely absent from these filings, limiting trend analysis; however, the filings reveal a severe lack of liquidity and governance failures. The most critical development is the absence of remediation plans from Lexaria and Northann, suggesting a high probability of actual delisting. The market implications are significant: investors face potential total losses in companies unable to cure deficiencies, while others may see dilution from reverse stock splits. A portfolio-level pattern is the concentration of distress in micro-cap and pre-revenue companies, where cash burn and governance lapses are acute.

5 high priority 5 total filings
· daily

US SEC Filings Daily Market Digest — August 10, 2026

The August 10, 2026, filing set reveals a mixed market landscape with notable divergences across sectors. Key themes include robust revenue growth in technology and aerospace, contrasted with margin compression and losses in healthcare and emerging tech. RadNet and Embraer stand out with strong operational performance and upward guidance revisions, signaling confidence in their respective markets. Conversely, AirSculpt Technologies and IonQ report widening losses despite revenue growth, highlighting challenges in scaling profitability. Insider activity is sparse, but capital allocation trends show a focus on reinvestment over shareholder returns. The most critical developments are Embraer's doubled free cash flow guidance and RadNet's record revenue, which have significant market implications for aerospace and diagnostic imaging sectors. Portfolio-level patterns indicate a bifurcation between established industrial and tech firms executing well versus growth companies facing profitability pressures.

9 high priority 41 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 10, 2026

Today's filings in the S&P 500 Consumer Discretionary sector are dominated by insider transactions, revealing a mixed but cautious sentiment among top executives. Director Fang Andy of DoorDash executed a planned sale of $3.23M in stock, while AutoZone's Sr. VP LeRiche Dennis W. realized a significant profit of ~$2.97M on a same-day option exercise and sale. In contrast, Amazon's CEO of Worldwide Stores, Herrington Douglas J., made a gift of 22,000 shares, a neutral signal often used for estate planning. NIKE announced a key executive transition with its VP and CAO resigning, adding a layer of operational uncertainty. The absence of forward-looking guidance or capital allocation changes across these filings suggests a period of relative stability, with insider activity providing the primary actionable intelligence for the day.

5 high priority 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 10, 2026

The nine filings from the S&P 500 Healthcare sector on August 10, 2026, reveal a bifurcated landscape. UnitedHealth Group stands out with a powerful operational turnaround, reporting a 61% surge in net earnings and a 55% jump in operating earnings, driven by a 4.1% reduction in medical costs, signaling strong managed care execution. In stark contrast, a wave of insider selling at Thermo Fisher Scientific, Merck, and Intuitive Surgical creates a bearish undercurrent, with executives liquidating significant holdings, often via 10b5-1 plans. The sector is characterized by a divergence between a dominant managed care player showing robust financial health and a cluster of life sciences and med-tech companies where insider sentiment is cautious. Capital allocation trends are mixed, with UnitedHealth aggressively returning capital via buybacks and dividends, while others show no such activity. The primary themes are operational efficiency versus insider skepticism, making UnitedHealth a clear standout for bullish investors, while the insider sales at other names warrant close monitoring for potential headwinds.

9 high priority 9 total filings
· daily

US Earnings Financial Results SEC Filings — August 10, 2026

The 50 filings for the period ending August 10, 2026, reveal a market characterized by stark divergence: established companies like Yum China, Brookfield Asset Management, and Berkshire Hathaway are posting strong operational results and returning significant capital to shareholders, while a cluster of pre-revenue and early-stage firms (Blue Biofuels, BTC Development, Invest Green Acquisition) continue to burn cash with no clear path to profitability. A notable theme is the prevalence of 'mixed' sentiment, with many companies showing top-line growth but facing margin compression or one-time charges that obscure underlying performance. Key period-over-period trends include a surge in M&A and divestiture activity (Plains All American, Berkshire Hathaway, Lincoln International), aggressive share repurchases (Corpay, Yum China, Berkshire Hathaway), and a sharp increase in operating expenses outpacing revenue growth at several firms (Axsome Therapeutics, Lincoln International, IonQ). The most critical development is the massive, non-cash-driven net income swings at companies like IonQ and Lincoln International, which require careful analysis to separate operational reality from accounting noise. Portfolio-level patterns point to a 'barbell' market where capital is flowing to either proven cash generators or high-risk, high-reward speculative plays, with the middle ground under significant pressure.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 10, 2026

This digest of 12 SEC proxy filings reveals a bifurcated landscape: mature, cash-rich companies like Darden Restaurants are delivering record sales and consistent shareholder returns, while a cluster of smaller, cash-burning entities (Glucotrack, Peraso, Toppoint) are resorting to dilutive capital raises, reverse stock splits, and reincorporations to stay afloat. The most material event is the $6.75/share acquisition of Atai Life Sciences by Eli Lilly, offering a clear near-term cash exit with an upside CVR. The SPAC space shows a high-risk, high-reward bet with NewHold's $2.35B nuclear energy merger, where public shareholders will be heavily diluted to just 6.7% ownership. Insider trading data is sparse, but the lack of insider buying at several distressed companies is a notable bearish signal. The dominant themes are capital structure distress (3 companies seeking reverse splits or massive share increases) and governance activism (AMC's declassification and written consent proposals). The overall tone is cautious, with significant dilution risk outweighing growth catalysts in the portfolio.

12 high priority 12 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 10, 2026

The IPO pipeline on August 10, 2026, is overwhelmingly dominated by SPAC registrations, with 5 of 10 filings being blank-check companies (Inflection Point VIII, Eaglesky, JATT III, Gores Holdings XII, GigCapital10) seeking to raise a combined $320M+ in gross proceeds. This SPAC wave signals renewed sponsor confidence in the de-SPAC market, though the sector focus remains broad and largely undisclosed. Notable is the absence of traditional operating company IPOs, with only Curis Inc. (a follow-on offering) and ClearOne Inc. (an early-stage S-1) representing non-SPAC equity raises. A significant cross-current is the business combination activity from Hannon Armstrong and MN8 Energy, both filed via S-4 registration statements, indicating ongoing M&A in the energy and infrastructure sectors. The most actionable insight is the Eaglesky Acquisition Corp filing, which explicitly excludes Chinese targets despite management's China ties, creating a unique risk/reward profile. Overall, the pipeline reflects a market cautiously re-embracing SPACs while traditional IPO windows remain narrow, with no period-over-period trends available as all filings are initial registrations.

10 high priority 10 total filings
· daily

US SEC Trading Suspension Halt Orders — August 10, 2026

This digest covers five regulatory filings related to US trading suspensions, delistings, and regulatory halts, all published on August 10, 2026. The overarching theme is a wave of Nasdaq compliance challenges, with three companies (Arcadia Biosciences, Construction Partners, and Northann Corp.) receiving or triggering delisting notices due to bid price, governance, or audit committee deficiencies. Lexaria Bioscience Corp. received a high-materiality delisting notice with no disclosed reason or remediation plan, representing the highest risk. In contrast, Faraday Future Intelligent Electric Inc. (FFAI) is the sole positive outlier, having regained compliance with Nasdaq's minimum bid price rule and announcing technological breakthroughs, though it still faces stock price volatility. Period-over-period comparisons are limited as most filings lack quantitative financial data, but insider activity and governance failures (e.g., Northann's unpaid board compensation and lapsed D&O insurance) signal severe operational distress. The most critical development is the cluster of delisting risks among small-cap and micro-cap companies, which could trigger forced selling by institutional investors and liquidity crushes. Portfolio-level patterns indicate a sector-wide struggle for small-cap biotech and EV companies to maintain listing standards, with reverse stock splits and governance fixes as common but uncertain remedies.

5 high priority 5 total filings
· daily

US Executive Officer Management Changes SEC — August 10, 2026

The August 10, 2026, filings reveal a significant wave of leadership transitions across US equities, with 37 filings covering executive and director changes. A key theme is the prevalence of planned and orderly successions, particularly in the energy and industrial sectors (e.g., Diversified Energy, U. S. Premium Beef, Infinity Natural Resources), which contrasts with a few sudden departures that raise governance flags (e.g., Diversified Energy CEO, Lincoln National CFO). Notable appointments include high-caliber executives from aerospace, fintech, and biotech, signaling strategic pivots toward growth and innovation. Insider activity is sparse, but the positive sentiment around new board members at Duolingo, Annexon, and Applied Aerospace suggests strong governance enhancements. Capital allocation trends are mixed, with Mueller Industries maintaining a steady dividend, while other companies focus on executive compensation adjustments. The overall market implication is a period of strategic repositioning, with investors advised to monitor the quality of succession planning and the experience of incoming leadership as key indicators of future performance.

37 high priority 37 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 10, 2026

The August 10, 2026 batch of 37 board and officer change filings reveals a high volume of leadership transitions, with a mix of planned successions, sudden departures, and strategic appointments. Notable trends include a wave of CFO transitions (Lincoln National, Infinity Natural Resources, NIKE, MicroVision), several board appointments bringing deep industry expertise (Atmos Energy, SAIC, Southwest Airlines, Duolingo, Werner), and a few high-risk sudden departures (Diversified Energy CEO, JOCOM Holdings overhaul). While most changes are routine, the lack of detail in several filings (e.g., Commercial Vehicle Group, ACV Auctions) and the sudden, unexplained CEO departure at Diversified Energy warrant caution. Positive sentiment dominates in filings with clear succession plans (U.S. Premium Beef, Owens & Minor), while the market should watch for potential instability at Diversified Energy and the strategic implications of new leadership at JOCOM and FingerMotion. No major period-over-period financial trends are available, but the concentration of CFO changes and the appointment of directors with strong capital markets experience suggest a focus on financial discipline and strategic growth.

37 high priority 37 total filings
· daily

USA Insider Trading Pulse — August 10, 2026

The August 10, 2026, insider trading pulse reveals a bifurcated market with strong insider conviction in select technology and financial names, contrasted by significant insider selling and option exercises in consumer and industrial sectors. The most critical development is the massive $13.6M sale by Floor & Decor's Executive Chair, which, despite being part of a planned exercise-and-sale, signals a potential top in the home improvement cycle. Conversely, a coordinated wave of small-scale insider buying across 10 executives at Taiwan Semiconductor (TSMC) provides a powerful, albeit symbolic, vote of confidence in the semiconductor leader. The data shows a clear pattern of insider buying in undervalued financials (Origin Bancorp, Bankwell) and beaten-down growth stories (PROCEPT BioRobotics, 51Talk), while insider selling is concentrated in companies with recent stock strength (Karooooo, InterDigital). The overall sentiment is mixed, with a slight bullish tilt from the number of buying transactions, but the sheer dollar volume of selling from top executives at Floor & Decor and Karooooo warrants caution.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 10, 2026

The August 10, 2026 M&A filing batch reveals a bifurcated SPAC market: while new IPOs (Pinnacle, East West Ave) continue to raise capital at $10/unit, the high-profile Yorkville-Crypto.com-TMTG deal collapsed, signaling waning SPAC appetite for complex transactions. Strategic acquisitions dominate, led by Amneal's transformative Kashiv BioSciences deal (biosimilars), Onto Innovation's $720M minority stake in Rigaku (semiconductor X-ray), and Ondas' Cyberhawk acquisition (drone inspection). Notable trends include a shift toward minority stakes and asset purchases with earn-outs (Byrna), reflecting disciplined capital deployment. Insider activity is limited, but sponsor ownership in East West Ave (15.12%) signals alignment. Forward-looking catalysts include Amneal's biosimilar launch cadence and Pinnacle's target search. Risks center on dilution (Ondas), deal termination fallout (Yorkville), and SPAC execution uncertainty (Dune, Quetta).

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 10, 2026

Overnight filings reveal a bifurcated market with strong growth in energy services and semiconductors contrasting with consumer and healthcare margin pressures. National Energy Services Reunited (NESR) posted record revenue (+59% YoY) and a 190% net income surge, while semiconductor firms ASE Technology and ChipMOS reported robust 43%+ YoY revenue growth. However, consumer-facing companies like AirSculpt Technologies (-3% revenue) and Dole plc (-14.8% Adj. EBITDA) face headwinds from input cost inflation. A notable capital allocation theme emerged: Yum China repurchased $530M in shares (6.7% share count reduction), while Berkshire Hathaway spent $4.5B on buybacks but saw cash drop 63% YoY due to $9.7B in acquisitions. The SPAC market showed renewed activity with two new IPOs (Eaglesky Acquisition Corp and Inflection Point Acquisition Corp VIII), signaling potential thawing. Insider trading data was sparse, but the delayed Q2 report from Beasley Broadcast Group due to debt restructuring tax accounting raises governance concerns. Overall, the data suggests rotating toward industrials/energy and away from consumer discretionary, while monitoring cash burn rates at pre-revenue companies like Blue Biofuels (cash down 66% to $22K).

9 high priority 41 medium 50 total filings
· daily

VA Healthcare & Services Contracts — August 09, 2026

This digest covers a single, large civilian contract from the Department of Veterans Affairs (VA) valued at $209.2 million, awarded to QTC Medical Services Inc., a subsidiary of Leidos Holdings, Inc. The contract, for medical disability examinations in the Southeast region, is a firm-fixed-price delivery order with a one-year performance period that has been nearly fully executed ($196.6M outlayed). While the award demonstrates Leidos' established position in the VA medical evaluation market, the neutral signal and lack of forward-looking growth visibility due to the short-term, completed nature of the contract limit bullish conviction. Key risks include the absence of a clear follow-on award and the fixed-price structure, which caps upside. The primary watch item is Leidos' ability to secure subsequent VA contracts in this or other regions to sustain this revenue stream.

1 total filings
· daily

HHS & Healthcare Contracts Intelligence — August 09, 2026

This digest covers a single, massive $626.5 million firm-fixed-price contract awarded to SIGA TECHNOLOGIES, INC. by the Department of Health and Human Services (HHS) / BARDA for late-stage development and procurement of a smallpox antiviral drug. The contract is entirely civilian (biodefense), not defense-related, and $447.2 million has already been outlayed, signaling strong government commitment. The highest-conviction signal is the long-term revenue visibility through 2029, though the fixed-price structure introduces execution risk if development costs exceed estimates. Key watch items include potential contract modifications and SIGA's cost performance relative to the fixed-price ceiling.

1 total filings